SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GESSI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.811
AS - Asia 15.861
EU - Europa 10.501
SA - Sud America 2.414
AF - Africa 321
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 12
Totale 56.946
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.211
SG - Singapore 5.642
CN - Cina 4.121
IT - Italia 3.013
BR - Brasile 1.879
DE - Germania 1.848
VN - Vietnam 1.768
UA - Ucraina 1.483
HK - Hong Kong 1.302
TR - Turchia 1.104
GB - Regno Unito 856
FI - Finlandia 695
FR - Francia 634
SE - Svezia 502
RU - Federazione Russa 477
BD - Bangladesh 443
JP - Giappone 391
IN - India 316
PL - Polonia 311
CA - Canada 297
MX - Messico 219
NL - Olanda 206
AR - Argentina 195
ID - Indonesia 136
IQ - Iraq 126
ZA - Sudafrica 117
ES - Italia 107
EC - Ecuador 81
CO - Colombia 73
PK - Pakistan 67
LT - Lituania 66
BE - Belgio 62
VE - Venezuela 57
UZ - Uzbekistan 54
CL - Cile 47
MA - Marocco 47
MY - Malesia 45
AE - Emirati Arabi Uniti 44
SA - Arabia Saudita 44
TN - Tunisia 38
AT - Austria 37
CZ - Repubblica Ceca 36
PH - Filippine 35
PY - Paraguay 30
KE - Kenya 29
NP - Nepal 24
JO - Giordania 22
AU - Australia 21
DZ - Algeria 19
EG - Egitto 19
IE - Irlanda 18
AL - Albania 17
IL - Israele 17
UY - Uruguay 17
IR - Iran 15
PE - Perù 15
JM - Giamaica 14
AZ - Azerbaigian 13
BO - Bolivia 13
RO - Romania 13
CH - Svizzera 12
KR - Corea 12
LB - Libano 12
PT - Portogallo 12
TW - Taiwan 12
CR - Costa Rica 11
OM - Oman 11
BG - Bulgaria 10
PS - Palestinian Territory 10
TH - Thailandia 10
GR - Grecia 9
HN - Honduras 9
HR - Croazia 8
HU - Ungheria 8
PA - Panama 8
RS - Serbia 8
ET - Etiopia 7
EU - Europa 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LV - Lettonia 7
SN - Senegal 7
SV - El Salvador 7
BA - Bosnia-Erzegovina 6
BY - Bielorussia 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
MN - Mongolia 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
AO - Angola 5
BH - Bahrain 5
CI - Costa d'Avorio 5
GE - Georgia 5
GY - Guiana 5
MD - Moldavia 5
MK - Macedonia 5
NG - Nigeria 5
QA - Qatar 5
SI - Slovenia 5
Totale 56.851
Salva come PNG Salva come JPEG
Città #
Singapore 3.665
Ashburn 2.903
Woodbridge 2.407
Fairfield 2.037
San Jose 1.889
Jacksonville 1.591
Chandler 1.581
Houston 1.503
Hong Kong 1.279
Beijing 1.220
Ann Arbor 1.187
Santa Clara 1.185
Wilmington 865
Seattle 839
Cambridge 671
Ho Chi Minh City 593
Izmir 518
Los Angeles 506
Dallas 496
Nanjing 490
Hanoi 428
Tokyo 373
Milan 364
Princeton 361
New York 352
Ferrara 328
Munich 305
Boardman 299
Lauterbourg 295
Warsaw 260
Helsinki 255
Shanghai 196
São Paulo 183
San Diego 173
Nanchang 165
Council Bluffs 155
Shenyang 152
Dearborn 149
Orem 134
London 130
Tianjin 126
Turku 126
Mexico City 125
Buffalo 119
Rome 119
Addison 111
Hefei 109
Bremen 104
Falkenstein 104
Changsha 102
Montreal 100
Hebei 98
Chicago 96
Frankfurt am Main 93
Da Nang 90
Brooklyn 83
Jakarta 80
Toronto 79
Bologna 78
Haiphong 75
The Dalles 74
Jiaxing 73
Chennai 70
Jinan 64
Denver 63
Johannesburg 62
Florence 61
Manchester 61
Stockholm 61
Atlanta 60
Moscow 60
Rio de Janeiro 60
San Mateo 60
San Francisco 58
Brussels 57
Norwalk 56
Phoenix 53
Mountain View 51
Zhengzhou 51
Baghdad 50
Boston 50
Tashkent 50
Amsterdam 49
Kunming 49
Poplar 49
Guangzhou 47
Mumbai 44
Falls Church 43
Belo Horizonte 41
Naples 41
Düsseldorf 38
Orange 36
Auburn Hills 35
Biên Hòa 35
Hải Dương 35
Redwood City 35
Verona 34
Ningbo 33
Philadelphia 32
Ankara 31
Totale 36.511
Salva come PNG Salva come JPEG
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.413
PRIN 2007 Coordinatore Nazionale del progetto Dott. Stefania Gessi- Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale 666
Pharmacology of Adenosine Receptors: The State of the Art 399
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 329
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 315
A glance at adenosine receptors: Novel target for antitumor therapy 308
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 302
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 298
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 289
The A3 adenosine receptor: history and perspectives 285
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 284
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 264
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 263
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 261
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 261
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 257
Adenosine receptors and human melanoma 255
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 255
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 253
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 250
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 245
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 245
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 243
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 242
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 242
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 242
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 237
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 236
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 234
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 234
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 228
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 228
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 226
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 226
Adenosine receptors and cancer 224
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 224
Adenosine receptor targeting in health and disease 223
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 221
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: Synthesis and affinity at 5-HT(2A), 5-HT(2B) and 5- HT(2C) serotonin receptors 219
van't Hoff Based Thermodynamics 219
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 217
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 217
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 217
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 215
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 215
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 215
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 213
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 211
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 211
Agonists and antagonists: Molecular mechanisms and therapeutic applications 211
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 210
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 209
Pathological overproduction: the bad side of adenosine 209
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 208
Targeting A3 and A2A adenosine receptors in the fight against cancer 208
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 208
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 207
Adenosine and lymphocyte regulation 206
Adenosine receptors in health and disease 205
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 204
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 204
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 204
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 202
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 202
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 202
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 202
Farmacologia cellulare e molecolare, sistemi di trasmissione. Trasmissione purinergica. 201
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 201
Binding thermodynamics at A1 and A2A adenosine receptors 200
Binding thermodynamics of 5-HT(1A) receptor ligands 200
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 200
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 200
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 200
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 199
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 197
Adenosine modulates HIF-1, VEGF, IL-8 and foam cells formation in a human model of hypoxic foam cells 196
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 196
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 196
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 195
A(2A) adenosine receptors in human peripheral blood cells 194
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 194
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 193
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 193
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 193
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 193
Adenosine receptors and cancer 193
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 192
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 192
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 192
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 191
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 191
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 190
Adenosine in a human model of Hypoxic foam cells 190
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 189
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 187
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 186
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 185
New potent and selective human adenosine A3 receptor antagonists. 185
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 184
Totale 23.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 237.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.051
Totale 249.841
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 0 0 0 0 0 0 232
2021/20223.182 68 328 207 157 141 135 118 174 113 266 459 1.016
2022/20233.721 360 289 119 500 617 497 183 308 461 43 202 142
2023/20242.024 181 253 100 48 230 217 101 133 51 96 100 514
2024/20257.724 188 220 612 424 973 666 314 473 1.036 864 1.071 883
2025/202621.490 2.183 823 1.824 2.718 3.007 1.456 2.498 1.120 2.100 2.428 858 475
Totale 57.363